Business
Results of Placing
Results of Placing.
About this update from Astrazeneca Plc
[{"type":"text","content":"\n \nRNS Number : 5633U AstraZeneca PLC 29 March 2019 \n\n29 March 2019\n \nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION \nTHIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES IN THE UNITED STATES, CANADA, SOUTH AFRICA, AUSTRALIA, JAPAN OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL.\nResults of Placing \n \nAstraZeneca PLC (the \"Company\" or \"AstraZeneca\") is pleased to announce the successful completion of the placing announced earlier today (the \"Placing\"). \nA total of 44,386,214 new ordinary shares of twenty-five cents each in the Company (the \"Placing Shares\") have been placed by Goldman Sachs International (\"Goldman Sachs\") and Morgan Stanley & Co. International plc (\"Morgan Stanley\") with both existing and new institutional investors at a price of £60.50 per Placing Share (the \"Placing Price\"), raising proceeds of approximately £2.69 billion ($3.5 billion at a GBP:USD average exchange rate of 1.3034) (before expenses). The Placing Shares being issued represent approximately 3.5 per cent. of the issued ordinary share capital of the Company. \nThe Placing Price of £60.50 each represents a discount of 1.5 per cent. to the middle market price at the time at which the Company, Goldman Sachs and Morgan Stanley agreed the Placing Price and complies with the guidance set out in the 'Statement of Principles' in respect of the disapplication of pre-emption rights issued by the Pre-Emption Group in 2015. The Placing Shares, when issued, will be credited as fully paid and will rank pari passu in all respects with the existing ordinary shares of twenty-five cents each in the capital of the Company, including the right to receive all dividends and other distributions declared, made or paid on or in respect of such shares after the date of issue. \nApplications have been made for admission of the Placing Shares to the premium listing segment of the Official List of the Financial Conduct Authority (the \"Official List\") and to trading on the main market of the London Stock Exchange plc (together, \"Admission\"). It is expected that settlement for t...